Selank
Synthetic peptide derived from tuftsin, discussed for potential anxiolytic and nootropic effects in experimental and regional clinical literature.
This page is for general educational and informational purposes only. It is not medical advice and does not replace professional medical judgment. Always consult a qualified clinician before starting, stopping, or changing any medication or protocol.
Overview
Selank is a synthetic peptide derived from tuftsin and has been studied primarily in certain Eastern European settings for potential anxiolytic and cognitive effects.
Outside those regions, selank is typically discussed in experimental or wellness contexts rather than as part of mainstream psychiatric or neurology guidelines.
Mechanism of action
Proposed mechanisms for selank include modulation of GABAergic signaling, effects on monoamine pathways, and influences on neuropeptides and neurotrophic factors.
The extent to which these mechanisms translate into clinically meaningful outcomes remains under investigation.
Indications and use context
In certain regional literature, selank has been explored in conditions related to anxiety and stress. Its regulatory approval and recommended uses, when present, are region-specific.
In many other jurisdictions, selank is not an approved medicine and is encountered in research or non-regulated markets.
Safety and side effects
Safety data for selank are limited and context-dependent.
Reported effects include local irritation (for nasal use) and nonspecific symptoms such as headache or fatigue. Long-term safety and interactions with other psychiatric therapies are not fully defined.
Pharmacology and dosing considerations
Selank is predominantly used as a nasal spray, though injectable forms exist. It is derived from the bioregulator Tuftsin.
- Dosage: 2–3 drops (approx 300–450 mcg total) in each nostril.
- Frequency: 2–3 times daily.
- Duration: Courses often last 10–14 days.
- Dosage: 250 mcg to 300 mcg daily.
This information summarizes commonly discussed practices, primarily from Eastern European literature.
Formulations and combinations
In catalogs, selank may appear as a solution or powder for reconstitution and can be grouped conceptually with other neuropeptides and nootropics.
Structural entries do not constitute endorsement of specific combination regimens.
Research and evidence snapshot
Studies of selank have examined endpoints related to anxiety, mood, and cognitive performance, primarily in specific regional populations.
Extrapolating these findings to broader practice requires careful attention to study quality, populations, and comparators.
Frequently asked questions
Future FAQs may address how selank compares conceptually with established anxiolytics or antidepressants, and how clinicians think about experimental neuropeptides in psychiatric care. Answers will remain educational and non-prescriptive.
Comments
Loading comments...
Get the Standard Protocols.
Join 12,000+ researchers. Receive weekly breakdowns of new compounds, safety data updates, and source verification reports.